190 related articles for article (PubMed ID: 12183047)
1. Cyclooxygenase-2-deficient mice are resistant to 1-methyl-4-phenyl1, 2, 3, 6-tetrahydropyridine-induced damage of dopaminergic neurons in the substantia nigra.
Feng ZH; Wang TG; Li DD; Fung P; Wilson BC; Liu B; Ali SF; Langenbach R; Hong JS
Neurosci Lett; 2002 Sep; 329(3):354-8. PubMed ID: 12183047
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease.
Teismann P; Ferger B
Synapse; 2001 Feb; 39(2):167-74. PubMed ID: 11180504
[TBL] [Abstract][Full Text] [Related]
3. COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice.
Feng Z; Li D; Fung PC; Pei Z; Ramsden DB; Ho SL
Neuroreport; 2003 Oct; 14(15):1927-9. PubMed ID: 14561922
[TBL] [Abstract][Full Text] [Related]
4. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
Zhang J; Graham DG; Montine TJ; Ho YS
J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
[TBL] [Abstract][Full Text] [Related]
5. Possible role of propofol's cyclooxygenase-inhibiting property in alleviating dopaminergic neuronal loss in the substantia nigra in an MPTP-induced murine model of Parkinson's disease.
Kubo K; Inada T; Shingu K
Brain Res; 2011 Apr; 1387():125-33. PubMed ID: 21376018
[TBL] [Abstract][Full Text] [Related]
6. [The effect of cyclooxygenase-2 on dopaminergic neurons in substantia nigra of Parkinson's disease mice induced by MPTP].
Li DD; Zhang WQ; Feng ZH
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2002 Nov; 18(4):333-6. PubMed ID: 21174803
[TBL] [Abstract][Full Text] [Related]
7. Lack of CCR5 modifies glial phenotypes and population of the nigral dopaminergic neurons, but not MPTP-induced dopaminergic neurodegeneration.
Choi DY; Lee MK; Hong JT
Neurobiol Dis; 2013 Jan; 49():159-68. PubMed ID: 22922220
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, neurochemical, stereological and neuropathological studies on the potential effects of paraquat in the substantia nigra pars compacta and striatum of male C57BL/6J mice.
Breckenridge CB; Sturgess NC; Butt M; Wolf JC; Zadory D; Beck M; Mathews JM; Tisdel MO; Minnema D; Travis KZ; Cook AR; Botham PA; Smith LL
Neurotoxicology; 2013 Jul; 37():1-14. PubMed ID: 23523781
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenases mRNA and protein expression in striata in the experimental mouse model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration to mouse.
Przybyłkowski A; Kurkowska-Jastrzebska I; Joniec I; Ciesielska A; Członkowska A; Członkowski A
Brain Res; 2004 Sep; 1019(1-2):144-51. PubMed ID: 15306248
[TBL] [Abstract][Full Text] [Related]
10. Estrogen attenuates the MPTP-induced loss of dopamine neurons from the mouse SNc despite a lack of estrogen receptors (ERalpha and ERbeta).
Shughrue PJ
Exp Neurol; 2004 Dec; 190(2):468-77. PubMed ID: 15530885
[TBL] [Abstract][Full Text] [Related]
11. Admixing of MPTP-Resistant and Susceptible Mice Strains Augments Nigrostriatal Neuronal Correlates to Resist MPTP-Induced Neurodegeneration.
Vidyadhara DJ; Yarreiphang H; Raju TR; Alladi PA
Mol Neurobiol; 2017 Oct; 54(8):6148-6162. PubMed ID: 27704331
[TBL] [Abstract][Full Text] [Related]
12. Neuroprotective effects of genistein on dopaminergic neurons in the mice model of Parkinson's disease.
Liu LX; Chen WF; Xie JX; Wong MS
Neurosci Res; 2008 Feb; 60(2):156-61. PubMed ID: 18054104
[TBL] [Abstract][Full Text] [Related]
13. Single low doses of MPTP decrease tyrosine hydroxylase expression in the absence of overt neuron loss.
Alam G; Edler M; Burchfield S; Richardson JR
Neurotoxicology; 2017 May; 60():99-106. PubMed ID: 28377118
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL/6 mice.
Mitsumoto Y; Watanabe A; Mori A; Koga N
Biochem Biophys Res Commun; 1998 Jul; 248(3):660-3. PubMed ID: 9703982
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 70 kDa over-expression and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced nigrostriatal degeneration in mice.
Gao L; Díaz-Martín J; Dillmann WH; López-Barneo J
Neuroscience; 2011 Oct; 193():323-9. PubMed ID: 21782904
[TBL] [Abstract][Full Text] [Related]
16. CEP-1347/KT-7515, an inhibitor of c-jun N-terminal kinase activation, attenuates the 1-methyl-4-phenyl tetrahydropyridine-mediated loss of nigrostriatal dopaminergic neurons In vivo.
Saporito MS; Brown EM; Miller MS; Carswell S
J Pharmacol Exp Ther; 1999 Feb; 288(2):421-7. PubMed ID: 9918541
[TBL] [Abstract][Full Text] [Related]
17. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
[TBL] [Abstract][Full Text] [Related]
18. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
19. Cooperative synthesis of dopamine by non-dopaminergic neurons as a compensatory mechanism in the striatum of mice with MPTP-induced Parkinsonism.
Kozina EA; Kim AR; Kurina AY; Ugrumov MV
Neurobiol Dis; 2017 Feb; 98():108-121. PubMed ID: 27940203
[TBL] [Abstract][Full Text] [Related]
20. Response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) differs in mouse strains and reveals a divergence in JNK signaling and COX-2 induction prior to loss of neurons in the substantia nigra pars compacta.
Boyd JD; Jang H; Shepherd KR; Faherty C; Slack S; Jiao Y; Smeyne RJ
Brain Res; 2007 Oct; 1175():107-16. PubMed ID: 17884023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
